http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108776747-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15831839ba3799f84b5c131e98fba73c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-18 |
| filingDate | 2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a219934f7e466b1b640c734b763d038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5b07029bc414572162454960cd6fbbc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3f4f6e1b58e299ad87b4589f6aedf14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca5892c2e54844fb9ae0f48f813226ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82251d4199ba8463aa87686f2858b2d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d11df64dfdf489bc247f1be150b74ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19014e62f1a66135a759dfc39e12be53 |
| publicationDate | 2018-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108776747-A |
| titleOfInvention | Zidovudine efficacy estimation method |
| abstract | The invention relates to a drug effect estimation method of zidovudine, comprising the following steps: obtaining the peak drug concentration of zidovudine target cells, obtaining the half-life concentration of target cells according to the peak drug concentration of target cells; Target cell drug peak concentration and target cell half-life time, target cell half-life concentration and the first formula obtain the relationship between the target cell drug concentration and administration time of zidovudine, and the first formula is: According to the relationship between the target cell drug concentration of zidovudine and the administration time, the relationship between the target cell drug concentration of the zidovudine phosphorylation product after 0.4-0.6h and the administration time was obtained. In this way, the drug effect of zidovudine in the target cells can be estimated only by obtaining the data of the peak concentration of the drug in the target cells. |
| priorityDate | 2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 936.